Kraig Biocraft Laboratories, a fully reporting biotechnology company is a leading developer of genetically engineered spider silk based fibre technologies. In response to increased demand, they have signed of a lease and will be taking possession of its new production facility in Indiana.

Kraig Biocraft Laboratories is moving rapidly to commercialize its spider silk technology, which it believes will have a significant impact on the global textiles industry.

The company has already begun interior construction and expects to have the facility ready for operations by 10 August 2016. This facility is expected to increase the company’s US production capacity by nearly twenty times.

This facility will be used to fulfil the company’s recently awarded contract from the US Government and to potentially supply additional collaborative textile developers.

COO Jon Rice said that this expanded domestic capacity should allow them to be more responsive to customers in both capacity and variety of spider silk materials.

This growth of their production capacity will allow them to expand their relationships with both industry and governmental collaborators. They are looking forward to the inauguration of this new production facility within the next two weeks.

The company said that its genetic engineering research has succeeded in developing a practical and cost-effective technology for producing recombinant spider silk based fibres on an industrial scale.